Update on human African trypanosomiasis (sleeping sickness)
- PMID: 31209574
- DOI: 10.1007/s00415-019-09425-7
Update on human African trypanosomiasis (sleeping sickness)
Abstract
Human African trypanosomiasis (HAT), also known as sleeping sickness, is one of the Africa's 'neglected diseases' and is caused by infection with protozoan parasites of the Trypanosoma genus. Transmitted by the bite of the tsetse fly, it puts 70 million people at risk throughout sub-Saharan Africa and is usually fatal if untreated or inadequately treated. In this brief overview, some important recent developments in this disease are outlined. These cover various aspects including a reduction in disease incidence, newly recognised parasite reservoir sites in humans, disease outcome, novel diagnostic methods, new and improved treatment, and disease neuropathogenesis.
Keywords: CNS; Diagnostic staging; Human African trypanosomiasis; Parasite; Sleeping sickness; Sub-Saharan Africa; Tsetse fly.
Similar articles
-
Priorities for the elimination of sleeping sickness.Adv Parasitol. 2012;79:299-337. doi: 10.1016/B978-0-12-398457-9.00004-4. Adv Parasitol. 2012. PMID: 22726645 Review.
-
Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.Front Immunol. 2019 Jan 25;10:39. doi: 10.3389/fimmu.2019.00039. eCollection 2019. Front Immunol. 2019. PMID: 30740102 Free PMC article. Review.
-
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).Lancet Neurol. 2013 Feb;12(2):186-94. doi: 10.1016/S1474-4422(12)70296-X. Epub 2012 Dec 21. Lancet Neurol. 2013. PMID: 23260189 Review.
-
Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.Acta Trop. 2017 Jan;165:230-239. doi: 10.1016/j.actatropica.2016.05.009. Epub 2016 May 19. Acta Trop. 2017. PMID: 27212706
-
The continuing problem of human African trypanosomiasis (sleeping sickness).Ann Neurol. 2008 Aug;64(2):116-26. doi: 10.1002/ana.21429. Ann Neurol. 2008. PMID: 18756506 Review.
Cited by
-
Analyzing editosome function in high-throughput.Nucleic Acids Res. 2020 Sep 25;48(17):e99. doi: 10.1093/nar/gkaa658. Nucleic Acids Res. 2020. PMID: 32756897 Free PMC article.
-
VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases.Vaccines (Basel). 2021 Mar 5;9(3):220. doi: 10.3390/vaccines9030220. Vaccines (Basel). 2021. PMID: 33807516 Free PMC article. Review.
-
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids.Nat Commun. 2024 Feb 27;15(1):1779. doi: 10.1038/s41467-024-46067-4. Nat Commun. 2024. PMID: 38413606 Free PMC article.
-
EpiBuilder: A Tool for Assembling, Searching, and Classifying B-Cell Epitopes.Bioinform Biol Insights. 2022 May 11;16:11779322221095221. doi: 10.1177/11779322221095221. eCollection 2022. Bioinform Biol Insights. 2022. PMID: 35571557 Free PMC article.
-
Centering Patient Expectations of a Novel Home-Based Oral Drug Treatment among T. b. rhodesiense Human African Trypanosomiasis Patients in Uganda.Trop Med Infect Dis. 2020 Jan 21;5(1):16. doi: 10.3390/tropicalmed5010016. Trop Med Infect Dis. 2020. PMID: 31973101 Free PMC article.